Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Europe’s BAPS Swaminarayan Sanstha is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.

Exterior of the Hindu temple, BAPS Shri Swaminarayan Mandir, in Neasden, London © Shutterstock
The Neasden Temple, London

Led by Oxford University researchers, the PRINCIPLE trial is working across all UK communities to evaluate if treatment administered early in the course of the Covid-19 illness can help people aged over 50 recover quickly, without the need for hospital admission.

Sadhu Yogvivekdas, Head of the BAPS Shri Swaminarayan Sanstha, UK & Europe, explained details of the trial to its vast network of worshipers and followers as part of an online sermon, explaining that those with Covid-19 symptoms can join online from home or via GP practices across the country, without the need for face-to-face visits.

While developing grassroots partnerships has been a major focus of the trial’s recruitment strategy so far, recruiting people from Black, Asian and minority ethnic communities has been a particular challenge.

The full story is available on the Nuffield Department of Primary Care Health Sciences website

Find out more about the PRINCIPLE trial

 

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.